The short arm of chromosome 8 undergoes frequent loss of heterozygosity (LOH) in ovarian adenocarcinomas. Fine mapping has identified several distinct critical regions within 8p which undergo rates of LOH of 50% or greater, suggesting that there may be more than one tumor suppressor gene located on this chromosome arm. In an effort to refine the location of these putative tumor suppressor genes by homozygosity-mapping-of-deletion analysis, we have analyzed 21 ovarian cancer cell lines with 19 polymorphic microsatellite markers from 8p. Eleven of the cell lines (55%) were homozygous at every marker, indicating loss of an entire 8p arm. No smaller extended regions of hemizygosity were identified. Refinement of these 8p target regions was ther...
Identification of the key genetic alterations leading to ovarian cancer is in its infancy. Polymeras...
The hypothesis that ovarian cancer is multifocal in origin was examined using molecular genetic tech...
A comprehensive understanding of the molecular vulnerabilities of every type of cancer will provide ...
Loss of heterozygosity (LOH) of the short arm of chromosome 8 occurs frequently in breast tumors. Fi...
Loss of heterozygosity (LOH) of the short arm of chromosome 8 occurs frequently in breast tumors. Fi...
In this study, 23 ovarian cancer cell lines were screened using array-comparative genomic hybridizat...
Loss of heterozygosity (LOH) on the short arm of chromosome 8, at 8p12-p23, is one of the most frequ...
Metaphase comparative genomic hybridisation (CGH) studies indicate that chromosomes 4, 5, 6, 13, 14,...
Ovarian carcinoma (OC) is the commonest gynaecological cause of death in the Western world. As a ste...
Several lines of evidence suggest that chromosome 8 is likely to harbor tumor-suppressor genes invol...
Loss of heterozygosity (LOH) on 8p occurs at high frequencies in many tumor types, including colorec...
The aim of this project was to characterise the rearrangements of 8p in multiple tumours and identif...
We have used polymerase chain reaction (PCR) amplification of tandem repeats to study the pattern of...
Cytogenetic, loss of heterozygosity (LOH) and midrocell-mediated chromosome transfer (MMCT) analyse...
Large-scale heterozygous deletions are a hallmark of cancer genome. Although with high recurrent fre...
Identification of the key genetic alterations leading to ovarian cancer is in its infancy. Polymeras...
The hypothesis that ovarian cancer is multifocal in origin was examined using molecular genetic tech...
A comprehensive understanding of the molecular vulnerabilities of every type of cancer will provide ...
Loss of heterozygosity (LOH) of the short arm of chromosome 8 occurs frequently in breast tumors. Fi...
Loss of heterozygosity (LOH) of the short arm of chromosome 8 occurs frequently in breast tumors. Fi...
In this study, 23 ovarian cancer cell lines were screened using array-comparative genomic hybridizat...
Loss of heterozygosity (LOH) on the short arm of chromosome 8, at 8p12-p23, is one of the most frequ...
Metaphase comparative genomic hybridisation (CGH) studies indicate that chromosomes 4, 5, 6, 13, 14,...
Ovarian carcinoma (OC) is the commonest gynaecological cause of death in the Western world. As a ste...
Several lines of evidence suggest that chromosome 8 is likely to harbor tumor-suppressor genes invol...
Loss of heterozygosity (LOH) on 8p occurs at high frequencies in many tumor types, including colorec...
The aim of this project was to characterise the rearrangements of 8p in multiple tumours and identif...
We have used polymerase chain reaction (PCR) amplification of tandem repeats to study the pattern of...
Cytogenetic, loss of heterozygosity (LOH) and midrocell-mediated chromosome transfer (MMCT) analyse...
Large-scale heterozygous deletions are a hallmark of cancer genome. Although with high recurrent fre...
Identification of the key genetic alterations leading to ovarian cancer is in its infancy. Polymeras...
The hypothesis that ovarian cancer is multifocal in origin was examined using molecular genetic tech...
A comprehensive understanding of the molecular vulnerabilities of every type of cancer will provide ...